The role of language in trial participation

Language shapes how participants understand a study. That may sound obvious, but it is regularly underestimated in practice. When trial materials are reviewed, most attention goes to regulatory accuracy. Emotional clarity comes second, if at all. Yet the words used in eConsent, instructions, app messages, and support emails have a direct effect on how comfortable participants feel and how likely they are to stay involved.

There is an important distinction between "accurate" and "understandable." Telling a participant they may experience a "mild to moderate gastrointestinal disturbance" is not the same as saying "you might feel bloated or have an upset stomach." Both are valid. But only one matches how people naturally talk and think about their health.

The evidence for this isn't just intuition. A randomised comparison of standard versus simplified consent forms for a cancer trial, using plain language, short sentences, diagrams, and pictures instead of dense clinical prose, found that the simplified version produced measurably better comprehension, both in objective testing and in how well participants said they understood it. The result held regardless of a participant's baseline health literacy: simplification didn't just help people who were already struggling, it improved understanding across the board. That's worth sitting with, because it means plain language isn't a concession made for a subset of participants. It's a better default for everyone.

The structure of a sentence carries meaning too

It is not just vocabulary. Sentence construction shifts how participants interpret their own responsibilities. "You must complete this form each day to remain in the study" reads like a threat. "This form helps us understand your experience. If you can complete it each day, that would be very helpful" invites cooperation. The first is rigid. The second is collaborative. In digital trials, where tone replaces face-to-face reassurance, that difference matters more than it would in a conversation with a coordinator who can soften a hard sentence with a smile.

Small changes, large effects

Here are some of the most common language problems in trial communications, and what to do instead:

• eConsent screens that say "click to acknowledge" shift the focus away from understanding. "Click to confirm you've read and understood this section" is more honest about what the action means.
• Reminder notifications that say "you missed your diary entry again" sound accusatory. "Your diary entry is ready whenever you are" maintains the invitation without pressure.
• Survey questions using terms like "adverse event" may be misunderstood by non-clinical participants. "Unexpected symptom or side effect" is clearer.
• Progress messages that count missed days create anxiety. Ones that acknowledge completed days build confidence.

Repetition creates a related problem worth planning for separately: participants tune out messages that feel generic or robotic. A notification that always says "task due today" eventually becomes noise, so varying the phrasing over the course of a long study, without changing what it actually asks of someone, keeps a reminder legible as a message rather than background static. None of this requires a full content strategy. It just requires someone to review the message library periodically and ask whether it still sounds human several weeks in.

Why it matters beyond compliance

When participants feel like a trial is speaking to them rather than at them, their behaviour changes. They complete tasks more consistently. They ask questions instead of guessing. They report accurately rather than rounding or approximating, which is exactly the kind of comprehension gap the consent form study was measuring, just extended into every other piece of communication a study sends.

They also talk about the study differently. A participant who feels respected tends to stay involved through difficult patches and mention the study positively to others. One who feels managed or unclear tends to disengage quietly.

In decentralised studies where human contact is reduced, the way we write may be the most human thing left. It is worth treating it that way.